TX // Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)
ANR <GO> NYSE RQD COCKPIT → CIK 0001342874 ↗| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $65.41 | $62.17 | 2025-02-14 | $49.19 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $68.12 | $63.79 | 2025-02-06 | $50.82 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $61.63 | $59.47 | 2025-01-29 | $51.90 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $55.14 | — | 2025-01-17 | $52.98 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $47.57 | $51.36 | 2025-01-09 | $48.11 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $64.33 | $56.22 | 2024-12-18 | $47.03 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $52.44 | $54.60 | 2024-12-04 | $50.28 | -4.3% | 48% | C |